1
Clinical Trials associated with Fecal Microbiota(University Hospital Heidelberg)Fecal Microbiota Transfer in Liver Cancer to Overcome Resistance to Atezolizumab/Bevacizumab (FLORA)
The interventional, randomized, placebo-controlled, single blind phase II-trial FLORA will assess safety and immunogenicity of fecal microbiota transfer in combination with standard of care immunotherapy in advanced hepatocellular carcinoma (HCC) in a parallel group design.
Subjects will be randomized 2:1 into either the FMT or placebo group.
100 Clinical Results associated with Fecal Microbiota(University Hospital Heidelberg)
100 Translational Medicine associated with Fecal Microbiota(University Hospital Heidelberg)
100 Patents (Medical) associated with Fecal Microbiota(University Hospital Heidelberg)
100 Deals associated with Fecal Microbiota(University Hospital Heidelberg)